Atreca Inc Cl A (BCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCEL | AZN | AMGN | GILD | BMY |
| Company | Atreca Inc Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0950 | 205.45 | 345.61 | 140.11 | 58.01 |
| High | 0.0950 | 206.73 | 351.33 | 141.45 | 59.04 |
| Low | 0.0900 | 204.27 | 342.35 | 138.47 | 57.67 |
| Latest | 0.0900 | 204.41 | 349.45 | 140.72 | 58.59 |
| Change | -0.0012 | +3.60 | +9.45 | +1.92 | +0.92 |
| % Change | -1.32% | +1.79% | +2.78% | +1.38% | +1.60% |
| Volume | 138,600 | 1,199,737 | 1,072,558 | 1,996,593 | 6,473,794 |
| 20-Day Average Volume | 104,865 | 1,846,938 | 2,615,063 | 5,950,184 | 13,324,429 |
| Previous Close | 0.0912 | 200.81 | 340.00 | 138.80 | 57.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0907 | 192.64 | 353.85 | 140.30 | 59.06 |
| 20-Day Raw Stochastic | 57.69% | 92.79% | 33.31% | 46.69% | 41.39% |
| 20-Day Relative Strength | 46.67 | 60.38 | 46.23 | 50.17 | 49.51 |
| Weighted Alpha | -88.45 | +54.06 | +22.98 | +35.96 | +22.31 |
| Today's Opinion | 56% Sell | 88% Buy | 40% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 40% Sell | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 72% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 06/07/24 | +3.93% since 03/31/26 | -0.50% since 03/31/26 | +1.23% since 03/31/26 | -2.98% since 03/31/26 |
| Low | 0.0864 on 06/10/24 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 0.0950 on 06/14/24 | 206.73 on 04/08/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -5.26% since 05/14/24 | +5.54% since 03/06/26 | -5.26% since 03/06/26 | -1.98% since 03/06/26 | -2.41% since 03/06/26 |
| Low | 0.0750 on 06/07/24 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.1010 on 05/21/24 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -54.77% since 03/14/24 | +9.02% since 01/08/26 | +6.05% since 01/08/26 | +16.92% since 01/08/26 | +5.26% since 01/08/26 |
| Low | 0.0520 on 03/19/24 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 0.2000 on 03/15/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -63.27% since 12/14/23 | +20.04% since 10/08/25 | +18.82% since 10/08/25 | +19.31% since 10/08/25 | +32.11% since 10/08/25 |
| Low | 0.0520 on 03/19/24 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.4448 on 01/12/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,566 | 311,437,824 | 183,283,120 | 172,281,616 | 117,746,848 |
| Shares Outstanding, K | 39,624 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -97,160,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -36,220,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.03 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/14/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 06/19/24 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.14 | 15.68 | 17.19 | 9.65 |